OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study
Rachel Knapp, F. Hardtstock, Julia Krieger, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104245-104245
Closed Access | Times Cited: 11
Rachel Knapp, F. Hardtstock, Julia Krieger, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 68, pp. 104245-104245
Closed Access | Times Cited: 11
Showing 11 citing articles:
Hypogammaglobulinemia and Infection Risk in an Ocrelizumab-treated Multiple Sclerosis Cohort
S Nobile, Philippe Beauchemin
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2024) Vol. 51, Iss. 6, pp. 811-818
Open Access | Times Cited: 3
S Nobile, Philippe Beauchemin
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2024) Vol. 51, Iss. 6, pp. 811-818
Open Access | Times Cited: 3
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
de Sèze, Dominique Dive, Xavier Ayrignac, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 519-533
Open Access | Times Cited: 2
de Sèze, Dominique Dive, Xavier Ayrignac, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 3, pp. 519-533
Open Access | Times Cited: 2
Infektionen und Multiple Sklerose
Felicita Heidler, Tobias Bopp, Matthias Schwab, et al.
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 2
Felicita Heidler, Tobias Bopp, Matthias Schwab, et al.
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 2
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: a multicentre study
Krzysztof Smolik, Federico Camilli, Ivan Panzera, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106191-106191
Open Access | Times Cited: 2
Krzysztof Smolik, Federico Camilli, Ivan Panzera, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 93, pp. 106191-106191
Open Access | Times Cited: 2
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials
Tobias Derfuß, Robert A Bermel, Chien-Ju Lin, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 1
Tobias Derfuß, Robert A Bermel, Chien-Ju Lin, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 1
Comparing the risk of serious infections in patients with and without MS: A German claims data analysis
Rachel Knapp, F. Hardtstock, Thomas Wilke, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 72, pp. 104583-104583
Closed Access | Times Cited: 1
Rachel Knapp, F. Hardtstock, Thomas Wilke, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 72, pp. 104583-104583
Closed Access | Times Cited: 1
Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis
Sarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1765-1775
Closed Access | Times Cited: 1
Sarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1765-1775
Closed Access | Times Cited: 1
Real-world infection risk in multiple sclerosis patients on long term immunomodulatory treatments
Clare Lambert, Taimoor Hussain, John Peters, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 94, pp. 106236-106236
Open Access
Clare Lambert, Taimoor Hussain, John Peters, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 94, pp. 106236-106236
Open Access
Multiple Sclerosis Pharmacology of Disease Modifying Therapies
Anza B. Memon, Ahmed Elrefaey, Robert P. Lisak, et al.
Elsevier eBooks (2024)
Closed Access
Anza B. Memon, Ahmed Elrefaey, Robert P. Lisak, et al.
Elsevier eBooks (2024)
Closed Access
Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records
Erwan Muros‐Le Rouzic, Marco Ghiani, Evi Zhuleku, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access
Erwan Muros‐Le Rouzic, Marco Ghiani, Evi Zhuleku, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access
Safety profile and adherence to treatment with ocrelizumab in multiple sclerosis – long-term observations
Anna Pokryszko−Dragan
Aktualności Neurologiczne (2023) Vol. 23, Iss. 3, pp. 105-110
Open Access
Anna Pokryszko−Dragan
Aktualności Neurologiczne (2023) Vol. 23, Iss. 3, pp. 105-110
Open Access
